We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$11.2B
AUM Growth
-$244M
Cap. Flow
-$183M
Cap. Flow %
-1.64%
Top 10 Hldgs %
22.89%
Holding
2,613
New
177
Increased
266
Reduced
1,243
Closed
46

Sector Composition

Rank Sector Weight
1 Technology 21.19%
2 Financials 13.17%
3 Healthcare 12.67%
4 Consumer Discretionary 11.48%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNTY
2426
DELISTED
Guaranty Bancshares
GNTY
$104K ﹤0.01%
+2,906
New +$98.8K
REVG
2427
DELISTED
REV Group
REVG
$104K ﹤0.01%
6,052
-4,799
-44% -$76.4K
HBIO icon
2428
Harvard Bioscience
HBIO
$28.1M
$103K ﹤0.01%
+1,483
New +$118K
ATLC icon
2429
Atlanticus Holdings
ATLC
$1.48B
$103K ﹤0.01%
+1,946
New +$95K
ATHX
2430
DELISTED
Athersys, Inc. Common Stock
ATHX
$103K ﹤0.01%
+3,095
New +$118K
ATER icon
2431
Aterian
ATER
$5.09M
$102K ﹤0.01%
+783
New +$86.8K
SMMF
2432
DELISTED
Summit Financial Group, Inc.
SMMF
$101K ﹤0.01%
+4,135
New +$96.6K
SGC icon
2433
Superior Group of Companies
SGC
$213M
$101K ﹤0.01%
+4,332
New +$102K
CSTE icon
2434
Caesarstone
CSTE
$104M
$101K ﹤0.01%
+8,108
New +$109K
ZY
2435
DELISTED
Zymergen Inc. Common Stock
ZY
$101K ﹤0.01%
7,633
ERNA icon
2436
Eterna Therapeutics
ERNA
$5.16M
$100K ﹤0.01%
1
BATRA icon
2437
Atlanta Braves Holdings Series A
BATRA
$3.63B
$99.9K ﹤0.01%
+3,713
New +$99.1K
TBHC
2438
DELISTED
The Brand House Collective
TBHC
$99.7K ﹤0.01%
+5,189
New +$102K
KRO icon
2439
KRONOS Worldwide
KRO
$905M
$99.2K ﹤0.01%
+7,992
New +$106K
MTRX icon
2440
Matrix Service
MTRX
$330M
$98.9K ﹤0.01%
+9,458
New +$101K
MPB icon
2441
Mid Penn Bancorp
MPB
$969M
$98.8K ﹤0.01%
+3,587
New +$95.9K
IMRX icon
2442
Immuneering
IMRX
$328M
$98.7K ﹤0.01%
+3,719
New +$99.9K
SCOR icon
2443
Comscore
SCOR
$108M
$98.7K ﹤0.01%
+1,265
New +$100K
TCRR
2444
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$98.6K ﹤0.01%
11,591
NUVL
2445
DELISTED
Nuvalent
NUVL
$98.5K ﹤0.01%
+4,369
New +$127K
LMNR icon
2446
Limoneira
LMNR
$251M
$98.1K ﹤0.01%
+6,067
New +$102K
HBMD
2447
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
$97.7K ﹤0.01%
+4,816
New +$92.2K
SNPO
2448
DELISTED
Snap One Holdings Corp. Common Stock
SNPO
$97.5K ﹤0.01%
+5,851
New +$109K
PKE icon
2449
Park Aerospace
PKE
$828M
$97.5K ﹤0.01%
+7,125
New +$104K
CRDF icon
2450
Cardiff Oncology
CRDF
$77.1M
$97.4K ﹤0.01%
+14,624
New +$91.9K

Similar funds

MetLife Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, MetLife Investment Management held 2,613 positions worth $11.2B, down 2.1% from $11.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

MetLife Investment Management's Q3 2021 filing shows 177 new, 266 increased, 1,243 reduced and 46 closed positions. Its largest new stake was Moderna: 79,316 shares worth $30.5M. The largest sale was Energy Transfer Partners, an estimated $35.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q3 2021 buy was Moderna: 79,316 shares worth $30.5M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $39.7M increase.
  • MetLife Investment Management's biggest Q3 2021 reduction was Energy Transfer Partners, cutting an estimated $35.7M.
  • MetLife Investment Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $9.28M.
  • MetLife Investment Management's ten largest holdings make up 23% of its $11.2B portfolio in Q3 2021.
  • MetLife Investment Management opened 177 new positions and closed 46 in Q3 2021.
  • MetLife Investment Management's portfolio value fell 2.1% quarter-over-quarter to $11.2B.

Based on MetLife Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.